Literature DB >> 23633431

Intrahemispheric and interhemispheric structural network abnormalities in PLS and ALS.

Federica Agosta1, Sebastiano Galantucci, Nilo Riva, Adriano Chiò, Stefano Messina, Sandro Iannaccone, Andrea Calvo, Vincenzo Silani, Massimiliano Copetti, Andrea Falini, Giancarlo Comi, Massimo Filippi.   

Abstract

Using diffusion tensor (DT) magnetic resonance imaging (MRI), damage to brain intrahemispheric and interhemispheric connections was assessed in 26 sporadic primary lateral sclerosis (PLS) patients compared with 28 sporadic amyotrophic lateral sclerosis (ALS) patients with similar disability and 35 healthy controls. DT MRI diagnostic accuracy in distinguishing the two motor neuron disease (MND) variants was tested. PLS and ALS patients showed a distributed pattern of abnormalities of the motor system, including the corticospinal tracts and corpus callosum (CC). PLS versus ALS patients showed a more severe damage to the motor CC fibers and subcortical white matter (WM) underlying the primary motor cortices. Both patient groups showed an extra-motor damage, which was more severe in PLS. This did not appear to be driven by longer disease duration in PLS. In PLS patients, damage to the CC mid-body correlated with the severity of upper motor neuron clinical burden. CC fractional anisotropy values had the highest accuracy in distinguishing PLS from controls and ALS. PLS and ALS share an overlapped pattern of WM abnormalities. This underscores that PLS, despite its distinct clinical phenotype and long survival, still lies within the wider MND spectrum. Whether CC diffusivity may be a novel marker to increase confidence in an early diagnostic separation of PLS from ALS still needs to be investigated.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  DT MRI; VBM; amyotrophic lateral sclerosis; brain atrophy; primary lateral sclerosis; white matter damage

Mesh:

Year:  2013        PMID: 23633431      PMCID: PMC6869498          DOI: 10.1002/hbm.22286

Source DB:  PubMed          Journal:  Hum Brain Mapp        ISSN: 1065-9471            Impact factor:   5.038


  43 in total

1.  Threshold-free cluster enhancement: addressing problems of smoothing, threshold dependence and localisation in cluster inference.

Authors:  Stephen M Smith; Thomas E Nichols
Journal:  Neuroimage       Date:  2008-04-11       Impact factor: 6.556

2.  White matter damage in frontotemporal lobar degeneration spectrum.

Authors:  F Agosta; E Scola; E Canu; A Marcone; G Magnani; L Sarro; M Copetti; F Caso; C Cerami; G Comi; S F Cappa; A Falini; M Filippi
Journal:  Cereb Cortex       Date:  2011-10-10       Impact factor: 5.357

3.  Primary lateral sclerosis: further clarification.

Authors:  N Le Forestier; T Maisonobe; L Spelle; A Lesort; F Salachas; L Lacomblez; Y Samson; P Bouche; V Meininger
Journal:  J Neurol Sci       Date:  2001-04-01       Impact factor: 3.181

4.  White matter alterations differ in primary lateral sclerosis and amyotrophic lateral sclerosis.

Authors:  Nobue K Iwata; Justin Y Kwan; Laura E Danielian; John A Butman; Fernanda Tovar-Moll; Elham Bayat; Mary Kay Floeter
Journal:  Brain       Date:  2011-07-28       Impact factor: 13.501

5.  Primary lateral sclerosis: upper-motor-predominant amyotrophic lateral sclerosis with frontotemporal lobar degeneration--immunohistochemical and biochemical analyses of TDP-43.

Authors:  Takayuki Kosaka; Yong-Juan Fu; Atsushi Shiga; Haruka Ishidaira; Chun-Feng Tan; Takashi Tani; Ryoko Koike; Osamu Onodera; Masatoyo Nishizawa; Akiyoshi Kakita; Hitoshi Takahashi
Journal:  Neuropathology       Date:  2011-11-21       Impact factor: 1.906

6.  A case of primary lateral sclerosis taking a prolonged clinical course with dementia and having an unusual dendritic ballooning.

Authors:  H Sugihara; M Horiuchi; T Kamo; K Fujisawa; M Abe; T Sakiyama; M Tadokoro
Journal:  Neuropathology       Date:  1999-01       Impact factor: 1.906

7.  Primary lateral sclerosis: a neuropsychological study.

Authors:  R J Caselli; B E Smith; D Osborne
Journal:  Neurology       Date:  1995-11       Impact factor: 9.910

8.  Clinicopathological features of primary lateral sclerosis are different from amyotrophic lateral sclerosis.

Authors:  A J Hudson; J A Kiernan; D G Munoz; C E Pringle; W F Brown; G C Ebers
Journal:  Brain Res Bull       Date:  1993       Impact factor: 4.077

9.  Amyotrophic lateral sclerosis with dementia: the clinicopathological spectrum.

Authors:  Mari Yoshida
Journal:  Neuropathology       Date:  2004-03       Impact factor: 1.906

10.  Cortical involvement in four cases of primary lateral sclerosis using [(11)C]-flumazenil PET.

Authors:  Martin R Turner; Alexander Hammers; Ammar Al-Chalabi; Christopher E Shaw; Peter M Andersen; David J Brooks; P Nigel Leigh
Journal:  J Neurol       Date:  2007-02-09       Impact factor: 4.849

View more
  33 in total

1.  Distributed corpus callosum involvement in amyotrophic lateral sclerosis: a deterministic tractography study using q-ball imaging.

Authors:  G Caiazzo; D Corbo; F Trojsi; G Piccirillo; M Cirillo; M R Monsurrò; F Esposito; Gioacchino Tedeschi
Journal:  J Neurol       Date:  2013-10-15       Impact factor: 4.849

2.  Brain MRI shows white matter sparing in Kennedy's disease and slow-progressing lower motor neuron disease.

Authors:  Edoardo G Spinelli; Federica Agosta; Pilar M Ferraro; Giorgia Querin; Nilo Riva; Cinzia Bertolin; Ilaria Martinelli; Christian Lunetta; Andrea Fontana; Gianni Sorarù; Massimo Filippi
Journal:  Hum Brain Mapp       Date:  2019-03-28       Impact factor: 5.038

3.  Regional alterations in cortical thickness and white matter integrity in amyotrophic lateral sclerosis.

Authors:  Jiuquan Zhang; Xuntao Yin; Lu Zhao; Alan C Evans; Lingheng Song; Bing Xie; Haitao Li; Chunxia Luo; Jian Wang
Journal:  J Neurol       Date:  2014-01-23       Impact factor: 4.849

Review 4.  Neuroimaging in genetic frontotemporal dementia and amyotrophic lateral sclerosis.

Authors:  Suvi Häkkinen; Stephanie A Chu; Suzee E Lee
Journal:  Neurobiol Dis       Date:  2020-09-02       Impact factor: 5.996

5.  The effect of network thresholding and weighting on structural brain networks in the UK Biobank.

Authors:  Colin R Buchanan; Mark E Bastin; Stuart J Ritchie; David C Liewald; James W Madole; Elliot M Tucker-Drob; Ian J Deary; Simon R Cox
Journal:  Neuroimage       Date:  2020-01-10       Impact factor: 6.556

6.  Brain white matter involvement in hereditary spastic paraplegias: analysis with multiple diffusion tensor indices.

Authors:  G Aghakhanyan; A Martinuzzi; F Frijia; M Vavla; H Hlavata; A Baratto; N Martino; G Paparella; D Montanaro
Journal:  AJNR Am J Neuroradiol       Date:  2014-04-30       Impact factor: 3.825

7.  Impaired corticopontocerebellar tracts underlie pseudobulbar affect in motor neuron disorders.

Authors:  Mary Kay Floeter; Rohan Katipally; Meredith P Kim; Olivia Schanz; Matthew Stephen; Laura Danielian; Tianxia Wu; Edward D Huey; Avner Meoded
Journal:  Neurology       Date:  2014-07-09       Impact factor: 9.910

8.  Primary lateral sclerosis and the amyotrophic lateral sclerosis-frontotemporal dementia spectrum.

Authors:  Smriti Agarwal; Elizabeth Highton-Williamson; Jashelle Caga; José M Matamala; Thanuja Dharmadasa; James Howells; Margaret C Zoing; Kazumoto Shibuya; Nimeshan Geevasinga; Steve Vucic; John R Hodges; Rebekah M Ahmed; Matthew C Kiernan
Journal:  J Neurol       Date:  2018-06-04       Impact factor: 4.849

9.  Structural brain correlates of cognitive and behavioral impairment in MND.

Authors:  Federica Agosta; Pilar M Ferraro; Nilo Riva; Edoardo G Spinelli; Adriano Chiò; Elisa Canu; Paola Valsasina; Christian Lunetta; Sandro Iannaccone; Massimiliano Copetti; Evelina Prudente; Giancarlo Comi; Andrea Falini; Massimo Filippi
Journal:  Hum Brain Mapp       Date:  2016-02-02       Impact factor: 5.038

10.  Cortical progression patterns in individual ALS patients across multiple timepoints: a mosaic-based approach for clinical use.

Authors:  Marlene Tahedl; Rangariroyashe H Chipika; Jasmin Lope; Stacey Li Hi Shing; Orla Hardiman; Peter Bede
Journal:  J Neurol       Date:  2021-01-05       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.